The ocrelizumab phase II extension trial suggests the potential to improve the risk: Benefit balance in multiple sclerosis
| Image |  |
|---|---|
| Description | scientific article published on 08 June 2020 |
| Author/s |
author: Monica Marta Klaus Schmierer |
| Publication date | June 8, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |